Market Quotes

5546 items in section

Consumer Stocks Slide as Service Inflation Clouds CPI Data

Consumer-sector equities retreated on Thursday as investors weighed a cooling headline inflation rate against a sharp spike in core service costs, casting doubt on the likelihood of near-term interest rate cuts. While the Consumer Price Index (CPI) decelerated to 2.4% in January, the underlying data revealed stubborn price pressures that offset broader market optimism.

Utilities Outpace S&P 500 on Falling Yields and AI Data Center Boom

Utility stocks rallied sharply as investors rotated into the sector, spurred by retreating Treasury yields and a loosening regulatory environment. The move highlights a growing confidence in power producers as both defensive 'bond proxies' and critical infrastructure beneficiaries of the global expansion in artificial intelligence.

Tech Stocks Edge Higher as AI Enthusiasm Meets Market Skepticism

Technology shares posted modest gains on Friday, even as investors grappled with shifting dynamics in the artificial intelligence sector and a broader retreat in mega-cap leaders. While infrastructure players like Arista Networks outperformed, a 1% dip in the Magnificent Seven ETF highlighted growing caution regarding the sustainability of the AI-driven rally.

Nutriband Scraps Pocono Pharmaceuticals Sale Over Missed Payments

Nutriband Inc. has officially terminated its agreement to sell subsidiary Pocono Pharmaceuticals to Earth Vision Bio, citing a failure by the buyer to meet financial obligations. The decision follows a series of missed late fees after the transaction failed to close by its original end-of-2025 deadline.

Ocular Therapeutix to Unveil Phase 3 Data for Axpaxli AMD Treatment

Ocular Therapeutix shares surged 15% in after-hours trading following the company’s announcement that it will release topline results from its Phase 3 clinical trial for Axpaxli this Tuesday. The study evaluates the treatment's efficacy for wet age-related macular degeneration (wet AMD), with the market anticipating key superiority data against current standards of care.

Enpro Raises Quarterly Dividend to 32 Cents per Share

Industrial technology specialist Enpro announced a 3.2% increase in its quarterly cash dividend on Friday, raising the payout to 32 cents per share. The board's decision brings the annualized distribution to $1.28, signaling a steady approach to shareholder returns and capital allocation.

Werewolf Therapeutics Slashes 64% of Staff as Top Executives Exit

Werewolf Therapeutics is undergoing a sweeping restructuring, cutting nearly two-thirds of its workforce and announcing the immediate departures of its finance and medical chiefs. The clinical-stage biopharmaceutical company expects to record a multi-million dollar charge as it drastically reduces its headcount to preserve capital.

PJM Approves 220-Mile NextEra-Exelon Mid-Atlantic Power Line

PJM Interconnection has approved a 220-mile electricity transmission line proposed by NextEra Energy and Exelon, a project designed to stabilize the power grid across West Virginia and Pennsylvania. The initiative comes as regional energy infrastructure faces mounting pressure from rising demand that is currently outpacing supply.

Badger Meter Doubles Share Buyback Program to $150 Million

Badger Meter’s board of directors has authorized a $75 million increase to its share repurchase program, effectively doubling the total capacity to $150 million through November 2028. The move underscores the water technology company's aggressive strategy to return capital to shareholders amid consistent financial performance.

Longeveron Appoints Biotech Veteran Stephen Willard as CEO

Clinical-stage biotechnology firm Longeveron has named industry veteran Stephen Willard as its new chief executive officer, effective Feb. 11. Willard, 65, takes the helm from interim leader Than Powell as the company seeks to stabilize its executive leadership and advance its clinical pipeline.

Cathay General Bancorp Increases Quarterly Dividend by 12%

Cathay General Bancorp announced a 12% increase to its quarterly cash dividend on Friday, raising the payout to 38 cents per share. The boost signals a strengthened capital return strategy for the financial holding company as it prepares for a March distribution to stockholders.

Enbridge CEO Rejects Risky Alberta Pipeline Expansion

Enbridge CEO Gregory Ebel has signaled the company will not pursue Alberta's proposed crude oil pipeline to the British Columbia coast, citing prohibitive political and policy risks. Speaking during a Friday earnings call, Ebel emphasized that the infrastructure giant is prioritizing stable investments over projects in jurisdictions with a history of regulatory uncertainty.

Gold Hits $5,022 as Trump’s 'Project Vault' Fuels Materials Rally

Shares of raw material producers climbed as gold futures surged 2% to $5,022 an ounce, marking a resilient recovery for precious metals. The rally comes as market analysts weigh the potential impact of the Trump administration’s proposed mineral stockpiling program on global supply chains and long-term inflation.

Antero Resources Settles Air Pollution Claims for $9.6 Million

Antero Resources Corporation has reached a settlement with the U.S. Department of Justice and West Virginia regulators to resolve alleged Clean Air Act violations across its regional energy operations. The agreement, announced Friday, requires the company to pay millions in penalties and commit to extensive infrastructure upgrades to curb emissions.

Electrovaya Shares Slide as Q1 Revenue Misses Wall Street Targets

Electrovaya shares tumbled Friday afternoon after the Canadian lithium-ion battery manufacturer reported fiscal first-quarter revenue that trailed Wall Street estimates, overshadowing a surprise jump in profitability. Despite the top-line miss, the company maintained an optimistic full-year outlook based on expanding market demand.

Brett Carter Resigns from Graco Board of Directors

Graco board member Brett Carter has resigned from his position effective Thursday, the industrial manufacturer disclosed in a regulatory filing. The departure, which the company confirmed was not the result of any internal disputes, marks an immediate exit for a director whose term was slated to run through 2027.

Bright Horizons Hits 52-Week Low as Earnings Miss Triggers Sell-Off

Bright Horizons Family Solutions shares plummeted on Friday, hitting a one-year low after the child care provider reported fourth-quarter earnings that significantly trailed analyst expectations. Despite a modest beat on revenue, the company’s net income fell to $21.7 million, sparking a 21% sell-off that extended a year-long decline for the stock.

Flowers Foods Shares Sink on Weak 2026 Outlook and Strategic Review

Flowers Foods shares plummeted 11% on Friday after the packaged bakery giant issued a disappointing 2026 forecast and announced a comprehensive strategic review to combat persistent industry headwinds. Despite beating fourth-quarter earnings estimates, the maker of Dave’s Killer Bread warned that a shorter fiscal year and shifting consumer habits would likely stifle growth in the coming year.

Chemed Expands Share Buyback Program With $300 Million Authorization

Chemed Corp. announced Friday that its board of directors has approved an additional $300 million for its share repurchase program, signaling a commitment to returning capital to investors. The company, which maintains a diverse portfolio ranging from hospice care to plumbing services, will integrate the new capacity into its existing repurchase framework.